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Herpetic Keratitis, Patience is a Virtue: HSK in Immunocompromised Patient
Abstract
Background: The Herpes virus is ubiquitous in our patient population. Often it is present without
symptoms, however, it may present with pain, irritation, and decreased vision. In high-risk populations a
longer course of treatment is often required.
Case Report: This case report will detail the treatment options and outcome in a patient with herpes
keratitis who also is HIV positive and addresses concerns about treating immunocompromised patients.
Conclusion: This case serves as a review of common and uncommon treatment options for herpes
keratitis as well as a review of potential causes of this presentation. Herpetic keratitis is likely to be
something most providers will encounter during their careers. Use of oral antivirals is often more cost
effect, better tolerated, and improves compliance.
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INTRODUCTION
Herpes simplex keratitis (HSK) presents after a patient has been exposed to
outside viral particles or after reactivation of the herpes simplex virus type 1 (HSV1) in their cornea. The cornea may respond differently depending on the anatomical
location involved.1Pertinent terminology may vary widely from one practitioner to
another2 and thus often results in inconsistent diagnosis and treatment from one
provider to another. The condition typically presents in otherwise healthy
individuals due to the almost ubiquitous presence of the virus within patients as
they age. 1,3,4
CASE REPORT
A 39-year-old African American male presented April 17, 2018 with complaints
of redness, photophobia, and decrease in vision in his left eye for about one week.
The patient reported being hospitalized for an unknown infection the previous
week. Systemic history review revealed a positive history of HIV that was being
treated with Norvir® (generic: ritonavir), Prezista® (generic: darunavir), and
Tivicay® (generic: dolutegravir) that he was taking with good compliance. These
medications are a part of the oft noted “HAART” therapy. While he did not recall
his most recent CD4 he thought it was “above 1600” and that his viral load was
undetectable at his last examination. He noted an allergy to azithromycin. A further
review of systems revealed that he had recently felt fatigued and that he has asthma.
The patient noted a history of redness in both eyes that occurred intermittently and
usually only lasted a day or two and resolved without the need for intervention. He
denied needing glasses. The patient was oriented to time, place, and person.
His distance vision upon initial examination was OD: 20/200 and OS: 20/25. The
use of a pinhole did not improve his vision in the right eye. His pupils were round
and reactive to light and accommodation. Extra ocular motilities (EOM) had full
range of motion in both eyes without pain or diplopia. Confrontation visual fields
(CFV) were full to finger counting in both eyes. Intraocular pressures were 11 mm
Hg in the right eye and 15 mm Hg in the left eye with a Tonopen at 10:11a m..
Anterior segment examination revealed 2+ injection on the right bulbar
conjunctiva, and trace injection on the left bulbar conjunctiva. The adnexa was
unremarkable with normal lids and lashes OU; the cornea in the right eye took stain
(Figure 1) and the left eye was negative for staining; irises were brown OU, anterior
chamber was without cells or flare, angles were open by Van Herick (4/4 OU), and
lenses were clear OU.
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Figure 1. The differential diagnoses considered in this case include: 2

•

•

•
•
•

•

Corneal abrasions can be present in patients of any age. However, they
often occur as a result of trauma or at least mechanical manipulation of
the eye. They are painful and can resolve either following intervention
or without it.
Recurrent corneal erosions occur after an initial corneal insult. They
typically occur upon awakening and will recur on an often infrequent
and inconsistent time schedule. They occur as a result of damage to the
corneal epithelium or epithelial basement membrane.
Vaccinia keratitis can occur following an inoculation or exposure to
smallpox. Vaccinia can be shed from the location of exposure and can
be spread by contact to the eye or periocular region.
Acanthamoeba keratitis is considered when the pain is disproportionate
to the patient’s ocular appearance (high pain with minimal findings).
Early in the disease process pseudodendrites can appear on the cornea.
Bacterial keratitis can result from ocular exposure to one of many
bacteria most commonly Staphylococcus, Streptococcus or
Pseudomonas. Frequently this presents with concurrent mucopurulent
discharge and anterior chamber reaction.
Herpes Zoster keratitis can present with corneal pseudodendrites
(Figure 2), however the keratitis typically presents following the
presentation of a skin rash. The timing of the presentation can vary in
immunocompromised patients. In the past, presentation of HZO in
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•

patients less than 40 years of age was thought to be a potential signifier
of HIV.
Herpes Simplex keratitis presents as a reactivation of the human herpes
virus type-1 and is thought to be brought on by fever, stress, trauma, or
ultraviolet light exposure. If keratitis is present, it is represented by
“true” dendrites with positive stain.

The patient denied any known insult, traumatic or mechanical. While having
experienced infrequent bouts of red eye in the past, each had resolved within a
couple of days. The patient denied any known exposure to smallpox or its vaccine.
His presentation revealed no mucopurulent discharge. This left Acanthamoeba,
Herpes Zoster, and Herpes Simplex as potential causes. There were no skin lesions
present however as indicated above, the keratitis can occur prior to dermatomal
rash. The stained corneal lesions were consistent with presentation of true dendrites
and thus a diagnosis of Herpes Simplex Keratitis was given. When distinguishing
true dendrites from pseudodendrites, one must focus on the presence or absence of
“terminal bulbs,” widenings at the end of the lesion. Additionally, it is helpful to
look for ulceration of dendrites.
The patient was started on oral acyclovir 400 mg 5x/day and trifluridine 9x/day
while awake. The patient was educated to the diagnosis and its prognosis (good).
The patient was unable to obtain the trifluridine from the pharmacy as it was not in
stock. It was stressed that he continue the oral acyclovir and RTC 4 in days for
reexamination.

FOLLOW UP #1
The patient did not attend the initially scheduled follow up due to transportation
difficulty. He instead returned one week from the initial visit. Upon presentation on
April 24, 2018, he denied any change in his medical history. He noted some
improvement in the vision in his right eye but denied much improvement in
photophobia and irritation. His distance vision in the right eye had improved from
20/200 to 20/60. His pupils, confrontation visual fields and extra ocular motilities
were all unchanged and normal OU. His intraocular pressures were 10 mm Hg and
12 mm Hg via Goldmann applanation tonometry at 10:30 am. His right eye still had
2+ injection. The corneal dendrites showed no significant change in appearance.
Upon follow up questioning the patient admitted to poor compliance with the oral
acyclovir due to the frequency of dosing necessary. The dilated exam revealed no
posterior segment involvement. He had clear vitreous OU; cup to disc ratio of 0.25r
with sharp margins OU; flat macula OU; normal vessels and no holes or tears in
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the periphery in both eyes. His medication was changed to oral valacyclovir 500
mg 2x/day. Due to the patient’s complaint of mildly worse pain, a prescription of
homatropine 5.0% BID, OD was added. Additionally, gentle corneal debridement
of the infected epithelium was performed with fair success. Much of one dendrite
was successfully removed while only some of the second dendrite could be
removed. Due to the lack of improvement and the initiation of active intervention
in office, the follow up was set for 3 days for the patient to be able to be seen prior
to the weekend.
FOLLOW UP #2
The patient followed up on April 26, 2018, and once again denied any changes in
his medical history. He noted an improvement in vision as well as a reduction of
photophobia despite not filling the homatropine prescription. The patient noted that
the cost of the medication was too high. The pupils, EOMs and CVF were all
unchanged. His vision had improved to 20/40+1 upon examination. The
conjunctival injection had improved from 2+ to 1+ at this visit. The dendrites had
gotten smaller but were still present. The importance of the oral valcyclovir was
stressed and the patient was scheduled for a follow up visit 4 days later.
FOLLOW UP #3
The patient made his final follow up on May 10th (after initially missing the
scheduled follow up). He had finished the course of valcyclovir and noted that his
vision had returned to normal. The pupils, EOMs and CVFs were all stable. His
vision had improved to 20/25. The conjunctival injection had improved from 1+ to
trace injection. The dendrites had resolved with only trace superficial punctate
keratitis present. The patient was presented with the option of continuing
preventative treatment but declined noting the “I probably wouldn’t last a week
without forgetting.” The patient was educated to follow up in 1 year or as needed.
Discussion
A subset of the Herpesviridae family Alphaherpesvirinae includes: Herpes
Simplex type 1 (HSV-1), Herpes Simplex Type 2 (HSV-2), and Herpes Varicella
Zoster (VZV) which are most pertinent for this discussion.3All three are double
stranded DNA.3 Present throughout the world, and with humans as the only known
natural reservoir, herpes is a virus faced by all humanity. Studies have shown that
greater than 90% of the world’s population test positive for the presence of HSV-1
within their trigeminal ganglia by the age of 60 years old. According to the United
Nations Economic and social affairs, the population 60+ in 2015 was 901 million
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people and is expected to rise to 1.4 billion by the year 2030.4 We can extrapolate
that, by those numbers, 1.26 billion people will test positive for the HSV-1 virus
within their trigeminal ganglion by the year 2030. Presence of HSV-1 within the
trigeminal ganglion does not necessarily indicate ocular complications. Herpes
Simplex Virus type 1 is responsible for oral infections, (commonly seen as “cold
sores) and is most frequently spread by oral-to-oral contact. The second virus HSV2 is spread through sexual contact and can result in genital sores. Although rare, the
HSV-1 virus can also cause genital herpes.4
Once someone has the virus, its appearance anywhere along the trigeminal
dermatome can be triggered by stress, fever, trauma, or ultraviolet exposure.1-4
Activation of the HSV-1 virus can affect skin/ eyelid, conjunctiva, cornea, anterior
chamber, or retina.
Transmission of the virus can occur through mechanical transfer from a localized
skin infection during the approximately 10 days it takes for the lesion to resolve.
The viral load can also be high enough in the saliva of an asymptomatic person that
contact with their saliva may be enough to transfer the virus to another person.1,4
Additionally, Kaufman et al. revealed that 98% of asymptomatic HSV-infected
patients secreted HSV-1 in either their tears or saliva.9 Of the 50 patients sampled
13/50 (26%) were IgG negative for HSV-1, thus, suggesting that seronegative
patients may have HSV present in either the trigeminal and/ or dorsal root ganglia.4

Figure 2.3 Trigeminal Nerve Pathway
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Skin:
A localized HSV-1 infection of the eyelid can be seen below7

Here we see small, localized elevations of the skin. They are a group of vesicles
with reddening of the tissue deep to them. The lesions have a scalloped border and
often have a “crust” due to fluid seepage. They tend to occur and then reoccur in
the same area and are typically self-limiting.
Cornea:
There are a variety of terms describing a herpes infection of the cornea. The
language used varies from provider to provider and between different disciplines.
Table 1 (below) summarizes the location involved as well as terms used to describe
it.4
Corneal Layer

Nomenclature

Epithelium

HSV epithelial keratitis
HSV stromal keratitis
without ulceration

Stroma

Endothelium

Alternate Terms
Dendritic epithelial ulcer
Geographic epithelial
ulcer
Non-necrotizing keratitis,
Interstitial keratitis,

Immune stromal keratitis
HSV stromal keratitis
with ulceration
Necrotizing keratitis
HSV endothelial keratitis Disciform keratitis

TABLE 1. HSV KERATITIS: CLASSIFICATION

The location and extent of the infection is important in determining the proper
treatment.
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Epithelium:
The corneal epithelium is involved in up to 2/3 of cases that present with ocular
involvement. Early lesions appear as superficial punctate keratitis which can form
into a dendrite within 12-24 hours. The dendrites form as the infected cell nuclei
expand with increasing concentrations of the replicated virus. These cells swell
until they burst, releasing high concentrations of the virus to neighboring cells.
1,10
The anatomic effect of the way the virus is passed is what provides “true
dendrites” with their classical “terminal bulbs.” The terminal bulbs are cells that
are swollen with virus that have not yet burst. If the infection continues to spread
through the epithelium it can lead to the destruction of the basement membrane. As
the basement membrane is responsible for maintaining the bond between the stroma
and endothelium, its erosion can lead to the formation of a “geographic ulcer.” If
the infection occurs near the limbus, the patient may be more symptomatic and may
take longer to respond to treatment. Damage to the cornea may result in the patient
suffering from recurrent corneal erosions or epithelial granularity. Opportunistic
infection may exacerbate the presentation, mandating further treatment.
Additionally, the infection may result in the patient having a neurotrophic cornea.
Stroma:
HSV-1 within the stroma causes swelling within the endothelium. It may present
either 1) with or without epithelial ulceration. The presence (or lack) of ulceration
allows us to decide whether the addition of topical steroids would be helpful. Severe
inflammation within the stroma can result in destruction and thinning of the corneal
stroma. This inflammation may even result in perforation of the cornea, although
that is uncommon unless another bacterial infection is also present. Stromal
neovascularization may also occur, and this may present in either a sectoral or
diffuse manner.1
Endothelium:
Inflammation of the endothelium is much less common than stromal inflammation
but may be present. There is difficulty in determining whether the edema present is
from a swelling of the stroma or endothelialitis. When endothelial edema is present
it tends to appear as a round swelling occupying the central or paracentral cornea.
It may be represented via a “ground glass” appearance. A linear endothelitis may
appear as a line of keratic precipitate.1
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Iridocorneal Endothelial Syndrome (ICE):
This condition was originally thought to have been a congenital abnormality
however it has been recently considered to be a result of HSV-1. ICE typically
presents with unilateral corneal edema, corectopia and presumed trabecular
abnormalities. The abnormal trabeculum is responsible for poorly draining the
aqueous thus resulting in an elevated intraocular pressure and potentially glaucoma.
When this is the case the unilateral corectopia is typically progressive.1

Treatment
Treatment involves either oral or topical antivirals. Oral antivirals include
acyclovir, valacyclovir and famciclovir; topical medications: trifluridine and
ganciclovir. See dosage chart below (Table 212).
Drug (Trade)
Acyclovir

Mechanism of Action Dosage
(MOA)
Interference with viral 400 mg 5x/day
DNA synthesis

Valacyclovir (Valtrex)

Prodrug for acyclovir

500 mg TID

Famciclovir (Famvir)

Inhibits DNA
elongation

Triflouridine
(Viroptic®)

Interference with viral Q2H until reepithelization
DNA synthesis
(10-14 days)

Ganciclovir (Zirgan®)

Interference with viral 5x/day
until
DNA synthesis and reepithelization, then TID
Inhibits DNA chain x 1 week
elongation

chain 250 mg TID

TABLE 212 DOSAGE CHART

Treatment can also include mechanical debridement the removal of affected cells
would seem to be helpful in reducing the time it takes to the viral concentration to
decrease. However, White and Chodosh reveal mixed results with this treatment
modality.4 When applied it should be in concurrence with either topical or oral
treatment. Further studies would be helpful in determining whether this helps to
improve outcomes.
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Immunocompromised
HSV can be an AIDs-defining opportunistic infection although the incidence of
HSV keratitis between HIV positive and HIV negative patients is fairly equal.4
Studies have found mixed results regarding a difference between presentation and
duration of treatment when comparing HIV (+) and HIV (-) patients4. More
research is needed in this area.
Preventative Treatment
The Herpetic Eye Disease Study (HEDs) study (1998) found that there was some
success in reducing recurrences of HSV keratitis and HSK stromal disease. In this
study, the necessary dosage was 400 mg BID oral acyclovir. This led to a decrease
in HSK recurrence of 45% and HSK stromal disease by 42%.1 However, there is
some concern about the usage of acyclovir and a potential for the virus to become
resistant.1,11 While the idea of preventing future occurrences of herpetic eye disease
have been proven possible, Lairson et al. have shown in a cost benefit analysis that
it would not be cost effective to try to treat every patient with herpetic keratitis with
preventive medication. Prophylactic treatment is a valuable tool in the provider’s
arsenal, but the determination of its applicability should be made on a situational
basis.
CONCLUSION
Herpes simplex keratitis can present in varying degrees of severity depending on
the individual case. The provider must take care to prescribe medication that can
be obtained, and the patient may need to show patience for results, especially if
immunocompromised. The use of corneal debridement may be considered on a
case-by-case basis but hasn’t shown to result in any significant difference in patient
outcomes. Additionally, the option of prophylactic treatment should be discussed,
but may not be a viable option for every case.
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